Navigation Links
Alexza Pharmaceuticals Reports 2010 Third Quarter Financial Results and Provides Business Update
Date:11/9/2010

from operations

(8,520)(13,007)(33,238)(36,685)Gain on change in fair value of contingent consideration liability

8,5096737,338673Interest and other income/ (expense), net

1942892Interest expense

(599)(95)(1,024)(378)Net loss

(591)(12,425)(26,896)(36,298)Consideration paid in excess of  noncontrolling interest

-(61,566)-(61,566)Net loss attributed to noncontrolling interest in Symphony Allegro, Inc.

-1,568-13,987Net loss attributable to Alexza common stockholders

$  (591)$(72,423)$ (26,896)$ (83,877)Net loss per share attributable to Alexza common stockholders

$
(0.01)$
(1.95)$
(0.50)$
(2.44)Shares used to compute basic and diluted net loss per share attributable to Alexza common stockholders

56,63937,06053,98734,388ALEXZA PHARMACEUTICALS, INC.(a development stage company)

CONDENSED CONSOLIDATED BALANCE SHEETS(in thousands)

(unaudited)September 30, December 31,20102009AssetsCash, cash equivalents and marketable securities

$
52,651$
9,916Other current assets1,3612,210Total current assets  

54,01222,126Property and equipment, net

24,92123,598Other non-current assets

4,516450Total assets

$
83,449$
46,174Liabilities and stockholders' deficitCurrent liabilities

$
56,918$
25,956Non-current liabilities

40,19027,344Stockholders' deficit

(13,659)(7,126)Total liabilities and stockholders' deficit

$
83,449$
46,174
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013  PENTAX Medical, a healthcare industry ... global leader in ultrasound imaging, recently announced renewed ... enable further innovation in the development of Endoscopic ... systems and PENTAX Medical endoscopic portfolio have formed ... EUS systems. This agreement will continue to grow ...
(Date:5/17/2013)... May 17, 2013 Oramed Pharmaceuticals ... oral drug delivery systems, announced today that the United ... Company,s Investigational New Drug application(IND) for ORMD-0801, its oral ... have the FDA clearance to proceed," stated ... trial is a major milestone for Oramed and we ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... Technology and Research (A*STAR) and Switzerland,s ... has been dosed in a Phase 1 clinical trial with ... Qbeta virus-like particle (VLP) technology. In this first Phase 1 ... candidate and its potential to protect against H1N1 influenza infection ...
Breaking Medicine Technology:PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
... 1, 2012 Anlit Advanced Nutrition Supplements ... dietary supplements for children, will present new and innovative products ... May 22-24, 2012 in Geneva, Switzerland. Anlit will ... Products Expo at Stand 3500. The company will present, ...
... SHENZHEN, China, April 30, 2012 /PRNewswire-Asia-FirstCall/ -- Mindray Medical ... developer, manufacturer and marketer of medical devices worldwide, announced ... Exchange Commission an Annual Report on Form 20-F that ... 31, 2011. An electronic version of Mindray,s Annual Report ...
Cached Medicine Technology:Anlit to Present New Dietary Supplements for Children at Vitafoods Europe 2012 2Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2
(Date:5/18/2013)... Also known as bariatric surgery , ... surgery that guarantees patients long-term weight loss. Dr. Naim ... give readers a brief tutorial on this revolutionary weight ... New York City’s Mount Sinai School of Medicine. After ... fellowship in Minimally Invasive Bariatric Surgery. He has also ...
(Date:5/18/2013)... News) -- Children who swallow high-powered magnets often need ... according to a new study. The researchers, from ... found that more than 79 percent of children who ... an endoscopic procedure, in which a tube containing a ... percent of these cases can be treated through observation ...
(Date:5/18/2013)... 2013) There are significant cost and risk ... diagnose or treat gastrointestinal problems, according to research ... A study by New York Presbyterian Hospital and ... may substantially reduce the cost and risk of ... believed to affect nearly 25 percent of adults, ...
(Date:5/18/2013)... A ground-breaking advance in colonoscopy technology signals ... presented today at Digestive Disease Week (DDW). Additional ... for colonoscopies and exploring safer methods for removing ... a device called a colonoscope to examine the ... a doctor to look for precancerous polyps called ...
(Date:5/18/2013)... May 17 (HealthDay News) -- It comes as little surprise ... that college women are more likely to drink unhealthy amounts ... Much of this difference is probably because the ... is much lower for women than it is for men: ... good reason for that difference. Women don,t metabolize alcohol in ...
Breaking Medicine News(10 mins):Health News:Everything You Need to Know About Lap Band Surgery 2Health News:Everything You Need to Know About Lap Band Surgery 3Health News:Swallowing Magnets Can Be Fatal for Children 2Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:New colonoscope provides ground-breaking view of colon 2Health News:New colonoscope provides ground-breaking view of colon 3Health News:New colonoscope provides ground-breaking view of colon 4Health News:College Women More Prone to Problem Drinking Than Men: Study 2Health News:College Women More Prone to Problem Drinking Than Men: Study 3
... , NEW ORLEANS Two new studies analyzing treatment ... light onto treatments aimed to extend the duration and ... Researchers from the Perelman School of Medicine at the ... minute to receive one treatment resulted in not living ...
... , FRIDAY, April 20 (HealthDay News) -- ... nearly four hours every day, new research finds. ... households with children ranging in age from 8 months ... consideration, such as the children,s gender, ethnicity, race, age ...
... FRIDAY, April 20 (HealthDay News) -- Depressed people may ... as peripheral artery disease (PAD), a new study suggests. ... the legs and pelvis. It was known that depression is ... its link with PAD specifically was unclear. In this ...
... Hopkins Bloomberg School of Public Health will host the ... descendants of the Transatlantic Slave Trade. The International Conference ... will explore the health status of people of ... Canada to Argentina. Today, there are approximately 160 million ...
... , THURSDAY, April 19 (HealthDay News) -- It,s ... long-term benefit from taking the blood sugar-lowering drug metformin and ... conclusion of Danish researchers who reviewed data from 23 clinical ... 18. Reporting online April 19 in the BMJ ...
... Reporter , THURSDAY, April 19 (HealthDay News) -- There were ... United States last year, more than four times the usual ... we had the most number of reported measles in the ... the National Center for Immunization and Respiratory Disease at the ...
Cached Medicine News:Health News:ALS patients differ on treatment choices in later phases of disease 2Health News:U.S. Children Exposed to Hours of Background TV Daily 2Health News:Depression Linked to Higher Odds for Poor Leg Circulation 2Health News:International conference to explore health of descendants of transatlantic slave trade 2Health News:Value of Metformin, Insulin Combo for Type 2 Diabetes Questioned 2Health News:Measles Outbreaks in 2011 Were Worst in 15 Years: CDC 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: